Uploaded August 2026 | Updated September 2026, 1 week ago
For families living with ADNP syndrome, the search for effective treatments is urgent and deeply personal. In this video, Oxford-Harrington Rare Disease Centre Scholar Dr. Joseph Buxbaum discusses his research to better understand ADNP syndrome and advance promising therapeutic approaches that could improve the lives of patients and families affected by this rare neurodevelopmental disorder.
The Oxford-Harrington Rare Disease Centre helps accelerate the development of new medicines for rare diseases by supporting leading researchers, fostering collaboration between academia and industry, and providing resources to move promising discoveries closer to patients. Established through a partnership between the University of Oxford and Harrington Discovery Institute at University Hospitals, the Oxford-Harrington Rare Disease Centre combines world-class scientific expertise with drug development support to help translate promising research into potential therapies for patients in need.
For families living with ADNP syndrome, the search for effective treatments is urgent and deeply personal. In this video, Oxford-Harrington Rare Disease Centre Scholar Dr. Joseph Buxbaum discusses his research to better understand ADNP syndrome and advance promising therapeutic approaches that could improve the lives of patients and families affected by this rare neurodevelopmental disorder.
The Oxford-Harrington Rare Disease Centre helps accelerate the development of new medicines for rare diseases by supporting leading researchers, fostering collaboration between academia and industry, and providing resources to move promising discoveries closer to patients. Established through a partnership between the University of Oxford and Harrington Discovery Institute at University Hospitals, the Oxford-Harrington Rare Disease Centre combines world-class scientific expertise with drug development support to help translate promising research into potential therapies for patients in need.










